Rapid Micro Biosystems, Inc.
RPID
$1.57
-$0.04-2.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.13% | 15.99% | 19.74% | 16.63% | 22.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.13% | 15.99% | 19.74% | 16.63% | 22.57% |
| Cost of Revenue | 18.63% | 19.92% | 15.55% | 2.68% | -0.78% |
| Gross Profit | -14.50% | -44.22% | 1,060.55% | 286.69% | 164.92% |
| SG&A Expenses | 10.94% | 7.23% | -1.07% | -5.88% | -6.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.22% | 9.12% | 3.86% | -2.71% | -3.33% |
| Operating Income | -7.99% | -4.81% | 5.06% | 12.47% | 15.12% |
| Income Before Tax | -15.96% | -11.81% | -0.46% | 8.44% | 12.57% |
| Income Tax Expenses | 240.91% | 57.69% | 81.82% | -56.41% | -38.89% |
| Earnings from Continuing Operations | -16.07% | -11.83% | -0.50% | 8.48% | 12.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.07% | -11.83% | -0.50% | 8.48% | 12.59% |
| EBIT | -7.99% | -4.81% | 5.06% | 12.47% | 15.12% |
| EBITDA | -9.26% | -5.80% | 4.93% | 13.11% | 16.13% |
| EPS Basic | -11.56% | -8.91% | 1.76% | 10.45% | 14.12% |
| Normalized Basic EPS | -11.46% | -8.88% | 1.81% | 10.40% | 14.07% |
| EPS Diluted | -11.56% | -8.91% | 1.76% | 10.45% | 14.12% |
| Normalized Diluted EPS | -11.46% | -8.88% | 1.81% | 10.40% | 14.07% |
| Average Basic Shares Outstanding | 4.13% | 2.63% | 2.25% | 2.13% | 1.73% |
| Average Diluted Shares Outstanding | 4.13% | 2.63% | 2.25% | 2.13% | 1.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |